Literature DB >> 9772865

Nephron-sparing surgery for renal cell carcinoma.

A C Novick1.   

Abstract

In summary, NSS is the indicated treatment for patients with localized RCC and an intercurrent urological or medical condition that poses a threat to overall renal function. Recent studies have clarified the role of NSS in patients with localized unilateral RCC and a normal contralateral kidney. Recent results indicate that radical nephrectomy and NSS provide equally effective curative treatment for patients who present with a single, small (< 4 cm), and clearly localized RCC. The long-term renal functional advantage of NSS with a normal opposite kidney requires further study.

Entities:  

Mesh:

Year:  1998        PMID: 9772865     DOI: 10.1046/j.1464-410x.1998.00751.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  6 in total

1.  Current limitations of radiofrequency ablation in renal cell carcinoma.

Authors:  Michael A S Jewett
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

2.  MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses.

Authors:  Catherine Roy; Benoit Sauer; Véronique Lindner; Hervé Lang; Christian Saussine; Didier Jacqmin
Journal:  Eur Radiol       Date:  2006-06-07       Impact factor: 5.315

3.  Nephron-sparing surgery for renal cell carcinoma.

Authors:  K H Tsui; A van Ophoven; O Shvarts; A Belldegrun
Journal:  Rev Urol       Date:  1999

4.  Psycho-social well-being and general health status after surgical treatment for localized renal cell carcinoma.

Authors:  Vincenzo Ficarra; Giovanni Novella; Alessandra Sarti; Giacomo Novara; Antonio Galfano; Stefano Cavalleri; Walter Artibani
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

5.  Open nephron-sparing surgery in renal tumors with normal contralateral kidney: A single centre experience of 8 years.

Authors:  N P Gupta; A Kumar; A K Hemal; P N Dogra; A Seth; R Kumar
Journal:  Indian J Urol       Date:  2007-01

6.  Radiofrequency ablation and cryoablation of renal tumours.

Authors:  K G Kwan; E D Matsumoto
Journal:  Curr Oncol       Date:  2007-02       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.